Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren vs enalapril for coronary microcirculation dysfunction in hypertension
2011-002587-24Phase 4Terminated
- Sponsor
- Fondazione Centro San Raffaele
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of aliskiren in hypertensive heart disease, Coronary Small Vessel Disease (CMD) and hypertension (HTN) (2 arms), sponsored by Fondazione Centro San Raffaele. Primary endpoint: Maximum myocardial blood flow difference. Started Jan 2012; status: terminated.
02
Drugs
aliskiren
03
Conditions
hypertensive heart diseaseCoronary Small Vessel Disease (CMD)hypertension (HTN)
Beyond the preview
Go deeper on 2011-002587-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002587-24.